Research ArticleGPCR SIGNALING

Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK

See allHide authors and affiliations

Science Signaling  20 Jun 2017:
Vol. 10, Issue 484, eaal3395
DOI: 10.1126/scisignal.aal3395

β-Arrestins not necessary

The β2-adrenergic receptor is thought to activate signaling mediated by the kinase ERK through a pathway that does not require G proteins but rather the β-arrestin family of scaffolding proteins. Biased agonists for the β2-adrenergic receptor are being developed to selectively activate this pathway. O’Hayre et al. took advantage of improved technologies for knocking out proteins in cells and unexpectedly found that β-arrestins were not required for ERK activation downstream of the β2-adrenergic receptor, although β-arrestin 2 was required for receptor internalization. Instead, the pathway depended on Gαs, Gβγ, and various other signaling molecules. These results suggest that biased agonists for the β2-adrenergic receptor may exert their effects in a β-arrestin–independent manner.

View Full Text

Stay Connected to Science Signaling